K2M Group (KTWO) Rating Lowered to Hold at BidaskClub
K2M Group (NASDAQ:KTWO) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.
Several other equities research analysts have also recently weighed in on the company. Zacks Investment Research upgraded K2M Group from a “sell” rating to a “hold” rating in a report on Thursday, January 25th. Barclays reiterated a “buy” rating and issued a $25.00 price objective on shares of K2M Group in a report on Tuesday, January 9th. Needham & Company LLC increased their price objective on K2M Group from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, January 9th. Wells Fargo & Co cut K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price objective for the company. in a report on Monday, December 4th. Finally, Oppenheimer reiterated a “buy” rating and issued a $24.00 price objective on shares of K2M Group in a report on Friday, November 10th. One analyst has rated the stock with a sell rating, three have given a hold rating and nine have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $24.50.
Shares of K2M Group (NASDAQ:KTWO) opened at $18.53 on Thursday. The firm has a market capitalization of $798.98, a PE ratio of -19.10 and a beta of 1.47. K2M Group has a fifty-two week low of $16.44 and a fifty-two week high of $25.99. The company has a current ratio of 3.06, a quick ratio of 1.67 and a debt-to-equity ratio of 0.29.
About K2M Group
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.